Related Articles
Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss
Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis
NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2
<em>Solanum nigrum</em> Line inhibits osteoclast differentiation and suppresses bone mineral density reduction in the ovariectomy‑induced osteoporosis model
Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation